发明授权
US06919359B2 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
失效
用于治疗疾病的氮杂双环取代的杂芳基化合物
- 专利标题: Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
- 专利标题(中): 用于治疗疾病的氮杂双环取代的杂芳基化合物
-
申请号: US10288863申请日: 2002-11-06
-
公开(公告)号: US06919359B2公开(公告)日: 2005-07-19
- 发明人: David W. Piotrowski , Jason K. Myers , Bruce N. Rogers , Eric Jon Jacobsen , Alice L. Bodnar , Vincent E. Groppi, Jr. , Daniel Patrick Walker , Brad A. Acker
- 申请人: David W. Piotrowski , Jason K. Myers , Bruce N. Rogers , Eric Jon Jacobsen , Alice L. Bodnar , Vincent E. Groppi, Jr. , Daniel Patrick Walker , Brad A. Acker
- 申请人地址: US NY New York
- 专利权人: Pfizer Inc
- 当前专利权人: Pfizer Inc
- 当前专利权人地址: US NY New York
- 代理商 Peter C. Richardson; Lorraine B. Ling; Eileen M. Ebel
- 主分类号: A61K31/407
- IPC分类号: A61K31/407 ; A61K31/422 ; A61K31/427 ; A61K31/4439 ; A61P25/00 ; A61P25/14 ; A61P25/16 ; A61P25/18 ; A61P25/20 ; A61P25/22 ; A61P25/24 ; A61P25/28 ; A61P25/30 ; A61P27/06 ; C07D401/12 ; C07D405/12 ; C07D409/12 ; C07D413/12 ; C07D417/12 ; C07D453/02 ; C07D471/08 ; C07D487/08 ; A61K31/44 ; C07D409/04
摘要:
The invention provides compounds of Formula I: Azabicyclo-N(R1)—C(═X)—W Formula I These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which α7 is known to be involved.
公开/授权文献
信息查询
IPC分类: